Abstract 358: EV-based delivery of chemically modified siRNA achieves MRTX1133-comparable efficacy in KRAS G12D-mutant pancreatic cancer.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: Ewha Womans University, Ewha Womans University Medical Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148694447
Cites:
Cited by:
Related to:
